Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
- 2012 -
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
August 2012 - 43 products
IP
CI
Diclo-Acino 10 mg/g
50 g
PR
PR
k.A.
Gel: Diclofenacum Natricum 10 mg
Acino Pharma AG
D
FB
G
IP
CI
Diclo-Acino 10 mg/g
100 g
PR
PR
k.A.
Gel: Diclofenacum Natricum 10 mg
Acino Pharma AG
D
FB
G
L
IP
CI
Methylphenidat Sandoz 18
30 Tablet(s)
26.83
45.60
10 %
Delayed release tablets: Methylphenidati Hydrochloridum 18 mg
Sandoz
Pharmaceuticals AG
● 
A+ / SL / SG
FB
G
L
IP
CI
Methylphenidat Sandoz 18
60 Tablet(s)
47.23
67.80
10 %
Delayed release tablets: Methylphenidati Hydrochloridum 18 mg
Sandoz
Pharmaceuticals AG
● 
A+ / SL / SG
FB
G
L
IP
CI
Methylphenidat Sandoz 27
30 Tablet(s)
33.38
52.70
10 %
Delayed release tablets: Methylphenidati Hydrochloridum 27 mg
Sandoz
Pharmaceuticals AG
A+ / SL / SG
FB
G
L
IP
CI
Methylphenidat Sandoz 27
60 Tablet(s)
58.74
80.30
10 %
Delayed release tablets: Methylphenidati Hydrochloridum 27 mg
Sandoz
Pharmaceuticals AG
● 
A+ / SL / SG
FB
G
L
IP
CI
Methylphenidat Sandoz 36
30 Tablet(s)
37.96
57.70
10 %
Delayed release tablets: Methylphenidati Hydrochloridum 36 mg
Sandoz
Pharmaceuticals AG
● 
A+ / SL / SG
FB
G
L
IP
CI
Methylphenidat Sandoz 36
60 Tablet(s)
66.81
89.10
10 %
Delayed release tablets: Methylphenidati Hydrochloridum 36 mg
Sandoz
Pharmaceuticals AG
● 
A+ / SL / SG
FB
G
L
IP
CI
Methylphenidat Sandoz 54
30 Tablet(s)
45.16
65.55
10 %
Delayed release tablets: Methylphenidati Hydrochloridum 54 mg
Sandoz
Pharmaceuticals AG
● 
A+ / SL / SG
FB
G
L
IP
CI
Methylphenidat Sandoz 54
60 Tablet(s)
79.48
102.85
10 %
Delayed release tablets: Methylphenidati Hydrochloridum 54 mg
Sandoz
Pharmaceuticals AG
● 
A+ / SL / SG
FB
G
L
IP
PP
Perjeta 420 mg
Durchstechflasche(n)
2835.34
3100.00
10 %
Concentrate for infusion: Pertuzumabum 420mg / 14ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
IP
CI
PP
Edarbi 20mg
28 Tablet(s)
19.37
37.50
10 %
Tablets: Azilsartanum Medoxomilum 20 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Edarbi 20mg
98 Tablet(s)
66.28
88.50
10 %
Tablets: Azilsartanum Medoxomilum 20 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Edarbi 40mg
28 Tablet(s)
21.93
40.25
10 %
Tablets: Azilsartanum Medoxomilum 40 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Edarbi 40mg
98 Tablet(s)
74.96
97.95
10 %
Tablets: Azilsartanum Medoxomilum 40 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Edarbi 80mg
28 Tablet(s)
26.61
45.35
10 %
Tablets: Azilsartanum Medoxomilum 80 mg
Takeda Pharma AG
B / SL
FB
G
IP
CI
PP
Edarbi 80mg
98 Tablet(s)
90.65
115.00
10 %
Tablets: Azilsartanum Medoxomilum 80 mg
Takeda Pharma AG
B / SL
FB
G
IP
SmofKabiven EF,
Infusionsemulsion 986 ml
4 x 986 ml
PR
PR
k.A.
16 Active Agents
Glucosum
3 Active Agents
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
SmofKabiven EF,
Infusionsemulsion 1477 ml
4 x 1477 ml
PR
PR
k.A.
16 Active Agents
Glucosum
3 Active Agents
Fresenius Kabi
(Schweiz) AG
B
FB
G
IP
Veletri 0.5mg
ampoule(s)
PR
PR
k.A.
Lyophilisate: Epoprostenolum
Janssen-Cilag AG
B
FB
G
IP
Veletri 1.5mg
ampoule(s)
PR
PR
k.A.
Lyophilisate: Epoprostenolum 1.5 mg
Janssen-Cilag AG
B
FB
G
IP
CI
PP
Edarbi 20mg
14
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 20 mg
Takeda Pharma AG
B
FB
G
IP
CI
PP
Edarbi 40mg
14
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 40 mg
Takeda Pharma AG
B
FB
G
IP
CI
PP
Edarbi 80mg
14
PR
PR
k.A.
Tablets: Azilsartanum Medoxomilum 80 mg
Takeda Pharma AG
B
FB
G
IP
CI
Firdapse
100 Tablet(s)
PR
PR
k.A.
Tablets: Amifampridinum 10 mg
DRAC AG
B
FB
G
IP
CI
Latanomed
2.5 ml
9.84
19.50
k.A.
Dermapharm AG
B
FB
G
IP
CI
Latanomed
3 x 2.5 ml
28.83
49.50
k.A.
Dermapharm AG
B
FB
G
IP
CI
Forielle Pen 300IE / 0.5 ml
Set(s)
PR
PR
k.A.
Merck (Schweiz) AG
A
FB
G
IP
CI
Forielle Pen 450IE / 0.75 ml
Set(s)
PR
PR
k.A.
Merck (Schweiz) AG
A
FB
G
IP
CI
Forielle Pen 900IE / 1.5 ml
Set(s)
PR
PR
k.A.
Merck (Schweiz) AG
A
FB
G
IP
CI
Dequalinium/Cinchocain-
Acino
30 Tablet(s)
PR
PR
k.A.
Lozenges: 2 Active Agents
Acino Pharma AG
D
FB
G
IP
CI
Pioglit-Mepha 15 mg
30 Tablet(s)
PR
PR
k.A.
Tablets: Pioglitazonum 15 mg
Mepha Pharma AG
B
FB
G
IP
CI
Pioglit-Mepha 15 mg
100 Tablet(s)
PR
PR
k.A.
Tablets: Pioglitazonum 15 mg
Mepha Pharma AG
B
FB
G
IP
CI
Pioglit-Mepha 30 mg
30 Tablet(s)
PR
PR
k.A.
Tablets: Pioglitazonum 30 mg
Mepha Pharma AG
B
FB
G
IP
CI
Pioglit-Mepha 30 mg
100 Tablet(s)
PR
PR
k.A.
Tablets: Pioglitazonum 30 mg
Mepha Pharma AG
B
FB
G
IP
CI
Pioglit-Mepha 45 mg
30 Tablet(s)
PR
PR
k.A.
Tablets: Pioglitazonum 45 mg
Mepha Pharma AG
B
FB
G
IP
CI
Pioglit-Mepha 45 mg
100 Tablet(s)
PR
PR
k.A.
Tablets: Pioglitazonum 45 mg
Mepha Pharma AG
B
FB
G
IP
Rienso
2 Durchstechflasche(n)
280.50
338.40
k.A.
Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml
Takeda Pharma AG
B
FB
G
IP
Rienso
6 Durchstechflasche(n)
PR
PR
k.A.
Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml
Takeda Pharma AG
B
FB
G
IP
Rienso
2 x 10 Durchstechflasche(n)
PR
PR
k.A.
Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml
Takeda Pharma AG
B
FB
G
IP
Rienso
6 x 10 Durchstechflasche(n)
PR
PR
k.A.
Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml
Takeda Pharma AG
B
FB
G
IP
Rienso
Durchstechflasche(n)
140.25
177.40
k.A.
Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml
Takeda Pharma AG
B
FB
G
IP
Rienso
10 Durchstechflasche(n)
PR
PR
k.A.
Lösung zur intravenösen Injektion: Ferrum 510mg / 17ml
Takeda Pharma AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home